# Trikafta in Cystic Fibrosis Patients

> **NCT03506061** · PHASE2 · COMPLETED · sponsor: **Emory University** · enrollment: 42 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** Trikafta

## Key facts

- **NCT ID:** NCT03506061
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-04
- **Primary completion:** 2024-02-13
- **Final completion:** 2024-02-13
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2025-09-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03506061

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03506061, "Trikafta in Cystic Fibrosis Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03506061. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*